Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review
According to Forbes, in October 2020, cannabidiol (CBD) sales in the United States reached $4.2 billion after the federal government legalized hemp-derived CBD in 2018 [1]. In addition, the World Health Organization (WHO) in 2019 re-classified CBD and <0.2{b574a629d83ad7698d9c0ca2d3a10ad895e8e51aa97c347fc42e9508f0e4325d} of delta-9-tetrahydrocannabinol (THC) as not under …

